The widower of a woman who committed suicide after taking the anti-depressant drug Paxil has won a significant ruling in his wrongful death suit against the drug’s manufacturer that allows him to pursue his claim that the company hid the truth about the drug’s side effects from the FDA.
In her 13-page opinion in Hoppe v. SmithKline Beecham Corp., Eastern District of Pennsylvania Judge Anita B. Brody refused to dismiss the suit on statute-of-limitations grounds, finding instead that the plaintiff must be allowed discovery on issues relating to when the manufacturer first learned of Paxil’s alleged risk of suicide.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
